Megan R. LaFollette, Clive Roper, Sally Thompson-Iritani
As scientists, regulators, and policymakers increasingly seek to reduce reliance on animal testing, “NAMs” are gaining attention. However, the acronym is used inconsistently, referring to New Approach Methodologies, Non-Animal Methods, and differing sets of technologies. This lack of clarity risks confusion, misaligned expectations, and inflated claims of progress. In this opinion paper, after a brief review of how NAMs have been defined across scientific and regulatory contexts, we propose a harmonized, goal-oriented definition applicable across sectors. A shared understanding of this key term will support transparent communication, meaningful evaluation, and effective adoption of these important technologies in research and regulatory contexts.